Abstract:Objective To investigate protective effect of Geniposide on renal interstitial fibrosis through TGF-β1/Smad-2 signaling pathway. Methods SD rats were randomly divided into control group (CG), and model group (MG), gavage group of normal rats, Geniposide group (30?mg/kg GG, or 15?mg/kg GG). Rat model of renal interstitial fibrosis was established by unilateral ureteral obstruction. The rats in geniposide group were continuously given geniposide for 14 days, while rats in control group and model group were given the same volume of saline. Pathological changes of renal interstitial fibrosis were observed by HE staining. Serum creatinine and urea nitrogen were detected by automatic biochemical analyzer. IL-1β, TNF-α and SOD were determined by ELISA. TGF-1β and Smad-2 protein expression were determined by western blotting Results Serum levels of inflammatory factor TNF-α, IL-1β and MDA were significantly decreased (P?0.05), and activity of SOD was significantly increased (P?0.05) in dose dependent manner in Geniposide group compared with those in the model group. Compared with the control group, expression of TGF-β1 and Smad-2 protein in renal tissue of model group increased significantly (P?0.05), which were reversed with treatment of Geniposide (30?mg/kg and 15?mg/kg, P?0.05). Conclusions Protective effect of Geniposide on renal interstitial fibrosis may be related to activation of TGF- β1/Smad signaling pathway, the reduction of inflammatory response and oxidative stress injury.